5 Best Japanese Stocks To Buy In 2024
Takeda Pharmaceutical Company Limited (NYSE:TAK) is a global pharmaceutical company engaged in the research, development, manufacturing, marketing, and out-licensing of pharmaceutical products.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Millennium Management Israel Englander | 6,492,911 | $92,653,840 | +73% | 0.04% |
2. | 948,300 | $13,532,241 | -1% | 0% | |
3. | D E Shaw D. E. Shaw | 214,957 | $3,067,436 | -20% | 0% |
4. | Hudson Bay Capital Management Sander Gerber | 175,000 | $2,497,250 | 0.01% | |
5. | Quantinno Capital Hoon Kim | 142,522 | $2,034,000 | -2% | 0.07% |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 14,297,805 | $204,029,677 | 0.05% | |
2. | 8,167,393 | $116,548,698 | 1.84% | |
3. | 4,847,535 | $69,174,354 | 0% | |
4. | 4,302,562 | $61,397,569 | 0.01% | |
5. | 2,651,265 | $37,833,550 | 0.57% |